‘Mostly FALSE’: NYT’s Claim That Trump Stands to Profit off of Hydroxychloroquine

 

The New York Times continues to try and sew division during a crisis. This time they stated that the President is going to benefit financially off of his touted drug hydroxychloroquine because of his stake in a pharmaceutical company.

The liberal fact-checker Snopes even rated this “mostly false” and only because President Trump has a negligible stake in the company.

According to The Daily Caller:

Snopes fact-checked a New York Times article that argued that President Donald Trump could stand to benefit financially from hydroxychloroquine being used to treat coronavirus patients, deeming the article “mostly false.”

The New York Times published an article Tuesday mentioning the president’s small financial stake Sanofi, a French  pharmaceutical company that produces the anti-malaria drug that has shown to be effective in treating the virus. Trump’s personal stake in the company is estimated to be as small as $99. The president’s net worth is estimated to be between 3 and $4 billion.

 

“Because Trump’s financial interest in Sanofi and other pharmaceutical companies is indirect and minor, and because hydroxychloroquine is an easily produced generic drug unlikely to drive profit, we rank the claim that his promotion of the drug could lead to potential financial benefits as ‘Mostly false,’” the left-leaning fact check outlet wrote.

The president has repeatedly touted the promise of hydroxychloroquine as a therapeutic for the virus and waived FDA regulations last month to allow the drug to be quickly approved for treatment. The drug has been rated as the “most effective” treatment for the coronavirus by thousands of physicians.

When President Trump first started calling the press “the enemy of the people” even most on the right thought it was taking things a little too far. But each day the mainstream media continues to prove President Trump correct in this characterization.


Comment

Your email address will not be published.

By submitting this form, I hereby consent to TrumpTrainNews.com's Terms of Use and Privacy Policy, which permits TrumpTrainNews.com and its affiliates to contact me.